Photodynamic Therapy PDT History and Modern Clinical Applications From Sunlight to Fluorescence Guided Cancer Surgery

Overview

The Royal Institution talk traces the evolution of photodynamic therapy (PDT) from 19th century sun based health treatments to modern clinical applications that use light activated drugs to target cancer and other diseases. It explains how light, drug, and oxygen together kill abnormal tissue and how this principle has been refined for internal use with endoscopes and CT guided interstitial delivery.

• Origins of heliotherapy and the birth of photodynamic concepts
• Mechanism: photosensitizer activation and singlet oxygen generation
• Clinical evolution from skin lesions to internal organs and brain tumors
• Key advantages and future directions including immunotherapy potential

Introduction and Historical Context

The talk begins with a historical overview of heliotherapy as a health treatment and charts how that interest in light therapy evolved into a scientific approach for medicine. A pivotal moment was the realization that ultraviolet light could kill bacteria, which inspired broader exploration of light driven therapies and the early idea that combining a chemical agent with light could destroy diseased tissue.

From Light, Drug and Oxygen to PDT Mechanism

Photodynamic therapy relies on three components: a photosensitizer drug, light that matches the absorption spectrum of the drug, and oxygen in the tissue. The early experiments in photodynamic therapy demonstrated that when a photosensitizer is activated by light, it reacts with oxygen to produce cytotoxic singlet oxygen, killing cancer cells while ideally sparing surrounding tissue.

Clinical Development and Endoscopy

For clinical use PDT began with superficial skin cancers and progressed to internal organs using endoscopes and targeted light delivery. The talk details endoscopic light delivery, fiber optics, and the use of lasers to illuminate areas inside hollow organs such as the bladder and esophagus. It also discusses the balance between achieving tumor control and preserving organ function to minimize scarring and obstruction.

Organ Specific Applications

Applications span the bladder, lungs and esophagus, with skin and lip cancers serving as early proving grounds. In hollow organs, the PDT effect tends to destroy the mucosal layer while preserving the underlying supportive tissue, allowing normal tissue to regenerate. The video includes case studies, imaging demonstrations, and discussion of the safety margins needed to avoid full thickness perforation or strictures.

Brain Tumors and Fluorescence Guided Surgery

A major focus is fluorescence guided resection in gliomas, where PDT photosensitizers illuminate tumor margins under blue light, guiding surgeons to remove cancerous tissue more precisely while protecting healthy brain. The talk explains how interstitial PDT can be delivered via multiple needles and image guided planning for difficult tumor locations within the brain, highlighting current challenges and ongoing trials.

Immunotherapy, Infections and Other Frontiers

Beyond direct cytotoxicity, PDT can interact with the immune system, potentially acting as an in vivo vaccine by provoking immune responses against cancer. The presentation also touches on antimicrobial uses, age related macular degeneration, and even exploratory ideas such as PDT based approaches to metabolic diseases and infection control.